ANNUAL CLINICAL UPDATES IN HEMATOLOGICAL MALIGNANCIES: A CONTINUING MEDICAL EDUCATION SERIES: Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and managementGARCIA-MANERO, Guillermo.American journal of hematology. 2011, Vol 86, Num 6, pp 491-498, issn 0361-8609, 8 p.Article

Integrating Care for Patients With Lower Risk Myelodysplastic SyndromeGARCIA-MANERO, Guillermo.Seminars in oncology. 2011, Vol 38, Num 5, pp 658-666, issn 0093-7754, 9 p.Article

Treatment of Higher-Risk Myelodysplastic SyndromeGARCIA-MANERO, Guillermo.Seminars in oncology. 2011, Vol 38, Num 5, pp 673-681, issn 0093-7754, 9 p.Article

Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and managementGARCIA-MANERO, Guillermo.American journal of hematology. 2012, Vol 87, Num 7, pp 693-701, issn 0361-8609, 9 p.Article

Continuing medical education activity in American Journal of HematologyTEFFERI, Ayalew; GARCIA-MANERO, Guillermo.American journal of hematology. 2012, Vol 87, Num 7, issn 0361-8609, p. 692Article

Current therapy of chronic myelogenous leukemiaGARCIA-MANERO, Guillermo; TALPAZ, Moshe; KANTARJIAN, Hagop M et al.Internal medicine (Tokyo. 1992). 2002, Vol 41, Num 4, pp 254-264, issn 0918-2918Article

Evolution of Decitabine Development : Accomplishments, Ongoing Investigations, and Future StrategiesJABBOUR, Elias; ISSA, Jean-Pierre; GARCIA-MANERO, Guillermo et al.Cancer. 2008, Vol 112, Num 11, pp 2341-2351, issn 0008-543X, 11 p.Article

Decitabine : In myelodysplastic syndromes. CommentaryMCKEAGE, Kate; GROOM, Katherine F; GARCIA-MANERO, Guillermo et al.Drugs (Basel). 2006, Vol 66, Num 7, pp 951-960, issn 0012-6667, 10 p.Article

Integrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolutionMONTALBAN BRAVO, Guillermo; LEE, Elinor; MERCHAN, Bryan et al.British journal of haematology. 2014, Vol 166, Num 5, pp 646-659, issn 0007-1048, 14 p.Article

Current and Future Management Options for Myelodysplastic SyndromesBRYAN, Jeffrey; JABBOUR, Elias; PRESCOTT, Hillary et al.Drugs (Basel). 2010, Vol 70, Num 11, pp 1381-1394, issn 0012-6667, 14 p.Article

Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemiaKOVITZ, Craig; KANTARJIAN, Hagop; GARCIA-MANERO, Guillermo et al.Blood. 2006, Vol 108, Num 8, pp 2811-2813, issn 0006-4971, 3 p.Article

The hyper-CVAD regimen in adult acute lymphocytic leukemiaGARCIA-MANERO, Guillermo; KANTARJIAN, Hagop M.Hematology/oncology clinics of North America. 2000, Vol 14, Num 6, pp x-xi, issn 0889-8588, 18 p.Article

Hypomethylating Agents and Other Novel Strategies in Myelodysplastic SyndromesGARCIA-MANERO, Guillermo; FENAUX, Pierre.Journal of clinical oncology. 2011, Vol 29, Num 5, pp 516-523, issn 0732-183X, 8 p.Article

Chronic myelogenous leukemia: A review and update of therapeutic strategiesGARCIA-MANERO, Guillermo; FADERL, Stefan; O'BRIEN, Susan et al.Cancer. 2003, Vol 98, Num 3, pp 437-457, issn 0008-543X, 21 p.Article

De Novo Acute Myeloid Leukemia Risk Factors: A Texas Case-Control StudySTROM, Sara S; OUM, Robert; ELHOR GBITO, Kplola Y et al.Cancer. 2012, Vol 118, Num 18, pp 4589-4596, issn 0008-543X, 8 p.Article

Potential Cure of Acute Myeloid Leukemia : Analysis of 1069 Consecutive Patients in First Complete RemissionYANADA, Masamitsu; GARCIA-MANERO, Guillermo; BORTHAKUR, Gautam et al.Cancer. 2007, Vol 110, Num 12, pp 2756-2760, issn 0008-543X, 5 p.Article

Salvage therapy for refractory or relapsed acute lymphocytic leukemiaGARCIA-MANERO, Guillermo; THOMAS, Deborah A.Hematology/oncology clinics of North America. 2001, Vol 15, Num 1, issn 0889-8588, viii,163-205 [44 p.]Article

Future directions for the use of hypomethylating agentsGARCIA-MANERO, Guillermo; GORE, Steven D.Seminars in hematology. 2005, Vol 42, Num 3, pp S50-S59, issn 0037-1963, SUP2Article

Fatal hepatic veno-occlusive disease in a phase I study of mylotarg and troxatyl in patients with refractory acute myeloid leukemia or myelodysplastic syndromeGILES, Francis; GARCIA-MANERO, Guillermo; O'BRIEN, Susan et al.Acta haematologica. 2002, Vol 108, Num 3, pp 164-167, issn 0001-5792Article

Ursodlol does not prevent hepatic venoocclusive disease associated with mylotarg therapyGILES, Francis; GARCIA-MANERO, Guillermo; CORTES, Jorge et al.Haematologica (Roma). 2002, Vol 87, Num 10, pp 1114-1116, issn 0390-6078Article

EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experienceJABBOUR, Elias; CORTES, Jorge; NAZHA, Aziz et al.Blood. 2012, Vol 119, Num 19, pp 4524-4526, issn 0006-4971, 3 p.Article

Outcome of Therapy-Related Acute Promyelocytic Leukemia With or Without Arsenic Trioxide as a Component of Frontline TherapyDAYYANI, Farshid; KANTARJIAN, Hagop; O'BRIEN, Susan et al.Cancer. 2011, Vol 117, Num 1, pp 110-115, issn 0008-543X, 6 p.Article

Survival Outcomes for Clonal Evolution in Chronic Myeloid Leukemia Patients on Second Generation Tyrosine Kinase Inhibitor TherapyVERMA, Dushyant; KANTARJIAN, Hagop; JIANQIN SHAN et al.Cancer. 2010, Vol 116, Num 11, pp 2673-2681, issn 0008-543X, 9 p.Article

Characteristics and outcomes of patients with chronic myeloid leukemia and T315Ι mutation following failure of imatinib mesylate therapyJABBOUR, Elias; KANTARJIAN, Hagop; JONES, Dan et al.Blood. 2008, Vol 112, Num 1, pp 53-55, issn 0006-4971, 3 p.Article

Outcome of Adults With Acute Lymphocytic Leukemia After Second Salvage TherapyO'BRIEN, Susan; THOMAS, Deborah; RAVANDI, Farhad et al.Cancer. 2008, Vol 113, Num 11, pp 3186-3191, issn 0008-543X, 6 p.Article